EUVIMEDEUVIMED entdecken
Open Access

Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men

Justine M Mucinski iD, David E Kelley, Stephen J Winters, Bret H Goodpaster

Obesity · 2025

DOI: 10.1002/oby.24269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity, 2025. Verfasst von Justine M Mucinski und 3 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Translational Research Institute, AdventHealth Orlando, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Sex Hormone-Binding Globulin, Testosterone, Weight Loss, Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Testosterone and glucose disposal (Rd) are positively associated in adult men, whereas the opposite is reported in women. Sex‐specific relationships between testosterone or sex hormone‐binding globulin (SHBG) and Rd in men and women with and without obesity and following weight loss were examined.

Methods

Adult men and women ( n = 27/28; BMI = 20–41 kg/m 2 ) underwent measurements of body composition, Rd, SHBG, and bioavailable (BioA) and total testosterone. Men and women ( n = 17/15) with obesity completed a 16‐week dietary weight‐loss program with repeat testing.

Results

BioA testosterone was lower in men with obesity and was related to Rd positively in men and negatively in women ( p < 0.05). Across participants, weight loss increased Rd and SHBG ( p < 0.01). BioA testosterone was unchanged in men; however, individual changes were independently related to Rd ( p = 0.031). In women, BioA testosterone declined ( p < 0.009) but was not related to Rd.

Conclusions

BioA testosterone was associated with Rd, positively in men and negatively in women. Weight loss reduced BioA testosterone in women; however, individual changes were associated with improved Rd in men. SHBG was a better correlate of improved Rd in women. Additional studies should identify mechanisms that drive sex differences and interventions that modify testosterone, reduce adiposity, and improve Rd across both sexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex Hormone-Binding GlobulinTestosteroneWeight LossObesityAdiposityInsulin ResistanceHumansFemaleMaleAdultMiddle AgedBody Mass IndexBody CompositionSex FactorsBlood Glucose

Substanzen

Sex Hormone-Binding GlobulinTestosteroneBlood GlucoseSHBG protein, human

Autor:innen und Institutionen

  • AdventHealth Translational Research Institute, AdventHealth Orlando, Orlando, Florida, USA.
  • Merck & Co. Inc., Kenilworth, New Jersey, USA.
  • Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA.

ORCID-Profile: Justine M Mucinski

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Mucinski, J. M., Kelley, D. E., Winters, S. J., & Goodpaster, B. H. (2025). Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men. Obesity. https://doi.org/10.1002/oby.24269

Vancouver

Mucinski JM, Kelley DE, Winters SJ, Goodpaster BH. Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men. Obesity. 2025. doi:10.1002/oby.24269

BibTeX
@article{Mucinski2025,
  author = {Mucinski, Justine M and Kelley, David E and Winters, Stephen J and Goodpaster, Bret H},
  title = {Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men},
  journal = {Obesity},
  year = {2025},
  doi = {10.1002/oby.24269}
}
Kostenlos starten →